Fragment-Based Drug Discovery Market Size, Share, Report to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Fragment-Based Drug Discovery Market Size Analysis

Global Fragment-Based Drug Discovery Market Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value

North America Market Analysis

Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value
U.S.
1. By Service Components
  1. Introduction
    1. Service Components By Value
  2. Fragment Screening
    1. By Value
    2. Biophysical Techniques
      1. Biophysical Techniques By Value
      2. NMR Spectroscopy
        
        NMR Spectroscopy By Value
      3. DSF Assay
        
        DSF Assay By Value
      4. Fluorescence Polarization (FP)
        
        Fluorescence Polarization (FP) By Value
      5. Isothermal Titration Calorimetry (ITC)
        
        Isothermal Titration Calorimetry (ITC) By Value
      6. X-ray Crystallography
        
        X-ray Crystallography By Value
      7. Surface Plasmon Resonance
        
        Surface Plasmon Resonance By Value
      8. Mass Spectrometry
        
        Mass Spectrometry By Value
      9. Capillary Electrophoresis
        
        Capillary Electrophoresis By Value
      10. Other Biophysical Techniques, Non-biophysical Techniques)
        
        Other Biophysical Techniques, Non-biophysical Techniques) By Value
    3. Non-Biophysical Techniques
      1. Non-Biophysical Techniques By Value
  3. Fragment Optimization
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Biopharmaceutical Companies
    1. By Value
  3. CROs
    1. By Value
  4. Academic and Research Institutions
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Central Nervous System (CNS) Disorders
    1. By Value
  4. Infectious Diseases
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Metabolic Disorders
    1. By Value
  7. Inflammation and Autoimmune Diseases
    1. By Value
Canada

Europe Market Analysis

Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value
U.K.
1. By Service Components
  1. Introduction
    1. Service Components By Value
  2. Fragment Screening
    1. By Value
    2. Biophysical Techniques
      1. Biophysical Techniques By Value
      2. NMR Spectroscopy
        
        NMR Spectroscopy By Value
      3. DSF Assay
        
        DSF Assay By Value
      4. Fluorescence Polarization (FP)
        
        Fluorescence Polarization (FP) By Value
      5. Isothermal Titration Calorimetry (ITC)
        
        Isothermal Titration Calorimetry (ITC) By Value
      6. X-ray Crystallography
        
        X-ray Crystallography By Value
      7. Surface Plasmon Resonance
        
        Surface Plasmon Resonance By Value
      8. Mass Spectrometry
        
        Mass Spectrometry By Value
      9. Capillary Electrophoresis
        
        Capillary Electrophoresis By Value
      10. Other Biophysical Techniques, Non-biophysical Techniques)
        
        Other Biophysical Techniques, Non-biophysical Techniques) By Value
    3. Non-Biophysical Techniques
      1. Non-Biophysical Techniques By Value
  3. Fragment Optimization
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Biopharmaceutical Companies
    1. By Value
  3. CROs
    1. By Value
  4. Academic and Research Institutions
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Central Nervous System (CNS) Disorders
    1. By Value
  4. Infectious Diseases
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Metabolic Disorders
    1. By Value
  7. Inflammation and Autoimmune Diseases
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value
China
1. By Service Components
  1. Introduction
    1. Service Components By Value
  2. Fragment Screening
    1. By Value
    2. Biophysical Techniques
      1. Biophysical Techniques By Value
      2. NMR Spectroscopy
        
        NMR Spectroscopy By Value
      3. DSF Assay
        
        DSF Assay By Value
      4. Fluorescence Polarization (FP)
        
        Fluorescence Polarization (FP) By Value
      5. Isothermal Titration Calorimetry (ITC)
        
        Isothermal Titration Calorimetry (ITC) By Value
      6. X-ray Crystallography
        
        X-ray Crystallography By Value
      7. Surface Plasmon Resonance
        
        Surface Plasmon Resonance By Value
      8. Mass Spectrometry
        
        Mass Spectrometry By Value
      9. Capillary Electrophoresis
        
        Capillary Electrophoresis By Value
      10. Other Biophysical Techniques, Non-biophysical Techniques)
        
        Other Biophysical Techniques, Non-biophysical Techniques) By Value
    3. Non-Biophysical Techniques
      1. Non-Biophysical Techniques By Value
  3. Fragment Optimization
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Biopharmaceutical Companies
    1. By Value
  3. CROs
    1. By Value
  4. Academic and Research Institutions
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Central Nervous System (CNS) Disorders
    1. By Value
  4. Infectious Diseases
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Metabolic Disorders
    1. By Value
  7. Inflammation and Autoimmune Diseases
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value
UAE
1. By Service Components
  1. Introduction
    1. Service Components By Value
  2. Fragment Screening
    1. By Value
    2. Biophysical Techniques
      1. Biophysical Techniques By Value
      2. NMR Spectroscopy
        
        NMR Spectroscopy By Value
      3. DSF Assay
        
        DSF Assay By Value
      4. Fluorescence Polarization (FP)
        
        Fluorescence Polarization (FP) By Value
      5. Isothermal Titration Calorimetry (ITC)
        
        Isothermal Titration Calorimetry (ITC) By Value
      6. X-ray Crystallography
        
        X-ray Crystallography By Value
      7. Surface Plasmon Resonance
        
        Surface Plasmon Resonance By Value
      8. Mass Spectrometry
        
        Mass Spectrometry By Value
      9. Capillary Electrophoresis
        
        Capillary Electrophoresis By Value
      10. Other Biophysical Techniques, Non-biophysical Techniques)
        
        Other Biophysical Techniques, Non-biophysical Techniques) By Value
    3. Non-Biophysical Techniques
      1. Non-Biophysical Techniques By Value
  3. Fragment Optimization
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Biopharmaceutical Companies
    1. By Value
  3. CROs
    1. By Value
  4. Academic and Research Institutions
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Central Nervous System (CNS) Disorders
    1. By Value
  4. Infectious Diseases
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Metabolic Disorders
    1. By Value
  7. Inflammation and Autoimmune Diseases
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service Components
1. Introduction
  1. Service Components By Value
2. Fragment Screening
  1. By Value
  2. Biophysical Techniques
    1. Biophysical Techniques By Value
    2. NMR Spectroscopy
      1. NMR Spectroscopy By Value
    3. DSF Assay
      1. DSF Assay By Value
    4. Fluorescence Polarization (FP)
      1. Fluorescence Polarization (FP) By Value
    5. Isothermal Titration Calorimetry (ITC)
      1. Isothermal Titration Calorimetry (ITC) By Value
    6. X-ray Crystallography
      1. X-ray Crystallography By Value
    7. Surface Plasmon Resonance
      1. Surface Plasmon Resonance By Value
    8. Mass Spectrometry
      1. Mass Spectrometry By Value
    9. Capillary Electrophoresis
      1. Capillary Electrophoresis By Value
    10. Other Biophysical Techniques, Non-biophysical Techniques)
      1. Other Biophysical Techniques, Non-biophysical Techniques) By Value
  3. Non-Biophysical Techniques
    1. Non-Biophysical Techniques By Value
3. Fragment Optimization
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Biopharmaceutical Companies
  1. By Value
3. CROs
  1. By Value
4. Academic and Research Institutions
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Central Nervous System (CNS) Disorders
  1. By Value
4. Infectious Diseases
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Metabolic Disorders
  1. By Value
7. Inflammation and Autoimmune Diseases
  1. By Value
Brazil
1. By Service Components
  1. Introduction
    1. Service Components By Value
  2. Fragment Screening
    1. By Value
    2. Biophysical Techniques
      1. Biophysical Techniques By Value
      2. NMR Spectroscopy
        
        NMR Spectroscopy By Value
      3. DSF Assay
        
        DSF Assay By Value
      4. Fluorescence Polarization (FP)
        
        Fluorescence Polarization (FP) By Value
      5. Isothermal Titration Calorimetry (ITC)
        
        Isothermal Titration Calorimetry (ITC) By Value
      6. X-ray Crystallography
        
        X-ray Crystallography By Value
      7. Surface Plasmon Resonance
        
        Surface Plasmon Resonance By Value
      8. Mass Spectrometry
        
        Mass Spectrometry By Value
      9. Capillary Electrophoresis
        
        Capillary Electrophoresis By Value
      10. Other Biophysical Techniques, Non-biophysical Techniques)
        
        Other Biophysical Techniques, Non-biophysical Techniques) By Value
    3. Non-Biophysical Techniques
      1. Non-Biophysical Techniques By Value
  3. Fragment Optimization
    1. By Value
2. By End-User
  1. Introduction
    1. End-User By Value
  2. Biopharmaceutical Companies
    1. By Value
  3. CROs
    1. By Value
  4. Academic and Research Institutions
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Central Nervous System (CNS) Disorders
    1. By Value
  4. Infectious Diseases
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Metabolic Disorders
    1. By Value
  7. Inflammation and Autoimmune Diseases
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Fragment-Based Drug Discovery Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Pfizer Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Novartis AG
Johnson & Johnson
Alveus Pharmaceuticals Pvt. Ltd.
Astex Pharmaceuticals
Charles River Laboratories International, Inc.
Beactica AB
Emerald BioStructures, Inc.
Crown Bioscience, Inc.
Evotec AG
Proteros Fragments GmbH
Kinetic Discovery Limited
Sprint Bioscience
Sygnature Discovery
Structure Based Design, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment